CoChat

Macrophage Migration Inhibitory Factor–CXCR4 Is the Dominant Chemotactic Axis in Human Mesenchymal Stem Cell Recruitment to Tumors

Open access
Lourenco, Sofia, Teixeira, Vitor H, Kalber, Tammy, Jose, Ricardo J, Floto, R Andres, Janes, Sam M · 2015 · The Journal of Immunology
Cited by 151

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Mesenchymal stromal cells (MSCs) are inherently tumor homing and can be isolated, expanded, and transduced, making them viable candidates for cell therapy. This tumor tropism has been used to deliver anticancer therapies to various tumor models. In this study, we sought to discover which molecules are the key effectors of human MSC tumor homing in vitro and using an in vivo murine model. In this study, we discover a novel role for macrophage migration inhibitory factor (MIF) as the key director of MSC migration and infiltration toward tumor cells. We have shown this major role for MIF using in vitro migration and invasion assays, in presence of different receptor inhibitors and achieving a drastic decrease in both processes using MIF inhibitor. Additionally, we demonstrate physical interaction between MIF and three receptors: CXCR2, CXCR4, and CD74. CXCR4 is the dominant receptor used by MIF in the homing tumor context, although some signaling is observed through CXCR2. We demonstrate downstream activation of the MAPK pathway necessary for tumor homing. Importantly, we show that knockdown of either CXCR4 or MIF abrogates MSC homing to tumors in an in vivo pulmonary metastasis model, confirming the in vitro two-dimensional and three-dimensional assays. This improved understanding of MSC tumor tropism will further enable development of novel cellular therapies for cancers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4049/jimmunol.1402097

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 50

  1. Chen, 2008, Transplanted bone marrow stromal cells migrate, differentiate and improve motor function in rats with experimentally induced cerebral stroke, J. Anat., 213, 249, 10.1111/j.1469-7580.2008.00948.x · DOI
  2. Askari, 2003, Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy, Lancet, 362, 697, 10.1016/S0140-6736(03)14232-8 · DOI · Paper page
  3. Zanjani, 1999, Homing of human cells in the fetal sheep model: modulation by antibodies activating or inhibiting very late activation antigen-4-dependent function, Blood, 94, 2515, 10.1182/blood.V94.7.2515.419k15_2515_2522 · doi:10.1182/blood.v94.7.2515.419k15_2515_2522
  4. Gao, 2009, Activation of signal transducers and activators of transcription 3 and focal adhesion kinase by stromal cell-derived factor 1 is required for migration of human mesenchymal stem cells in response to tumor cell-conditioned medium, Stem Cells, 27, 857, 10.1002/stem.23 · DOI · Paper page
  5. Komarova, 2010, Targeting of mesenchymal stem cells to ovarian tumors via an artificial receptor, J. Ovarian Res., 3, 12, 10.1186/1757-2215-3-12 · DOI
  6. Ara, 2003, Long-term hematopoietic stem cells require stromal cell-derived factor-1 for colonizing bone marrow during ontogeny, Immunity, 19, 257, 10.1016/S1074-7613(03)00201-2 · DOI · Paper page
  7. Geminder, 2001, A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma, J. Immunol., 167, 4747, 10.4049/jimmunol.167.8.4747 · DOI · Paper page
  8. Sun, 2003, Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo, J. Cell. Biochem., 89, 462, 10.1002/jcb.10522 · DOI · Paper page
  9. Porcile, 2004, CXCR4 activation induces epidermal growth factor receptor transactivation in an ovarian cancer cell line, Ann. N. Y. Acad. Sci., 1030, 162, 10.1196/annals.1329.021 · DOI
  10. Phillips, 2003, The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases, Am. J. Respir. Crit. Care Med., 167, 1676, 10.1164/rccm.200301-071OC · DOI · Paper page
  11. Bando, 2002, Expression of macrophage migration inhibitory factor in human breast cancer: association with nodal spread, Jpn. J. Cancer Res., 93, 389, 10.1111/j.1349-7006.2002.tb01269.x · DOI
  12. Kamimura, 2000, Intracellular distribution of macrophage migration inhibitory factor predicts the prognosis of patients with adenocarcinoma of the lung, Cancer, 89, 334, 10.1002/1097-0142(20000715)89:2<334::AID-CNCR18>3.0.CO;2-N · doi:10.1002/1097-0142(20000715)89:2<334::aid-cncr18>3.0.co;2-n
  13. Markert, 2001, Differential gene expression profiling in human brain tumors, Physiol. Genomics, 5, 21, 10.1152/physiolgenomics.2001.5.1.21 · DOI · Paper page
  14. Meyer-Siegler, 1998, Expression of macrophage migration inhibitory factor in the human prostate, Diagn. Mol. Pathol., 7, 44, 10.1097/00019606-199802000-00008 · doi:10.1097/00019606-199802000-00008
  15. Shimizu, 1999, High expression of macrophage migration inhibitory factor in human melanoma cells and its role in tumor cell growth and angiogenesis, Biochem. Biophys. Res. Commun., 264, 751, 10.1006/bbrc.1999.1584 · DOI · Paper page
  16. Takahashi, 1998, Involvement of macrophage migration inhibitory factor (MIF) in the mechanism of tumor cell growth, Mol. Med., 4, 707, 10.1007/BF03401765 · DOI · Paper page
  17. Winner, 2007, Macrophage migration inhibitory factor manipulation and evaluation in tumoral hypoxic adaptation, Methods Enzymol., 435, 355, 10.1016/S0076-6879(07)35018-0 · DOI
  18. Han, 2008, Expression of macrophage migration inhibitory factor relates to survival in high-grade osteosarcoma, Clin. Orthop. Relat. Res., 466, 2107, 10.1007/s11999-008-0333-1 · doi:10.1007/s11999-008-0333-1
  19. Meyer-Siegler, 2002, Macrophage migration inhibitory factor evaluation compared with prostate specific antigen as a biomarker in patients with prostate carcinoma, Cancer, 94, 1449, 10.1002/cncr.10354 · DOI
  20. Tomiyasu, 2002, Quantification of macrophage migration inhibitory factor mRNA expression in non-small cell lung cancer tissues and its clinical significance, Clin. Cancer Res., 8, 3755
  21. Borghese, 2011, CD74: an emerging opportunity as a therapeutic target in cancer and autoimmune disease, Expert Opin. Ther. Targets, 15, 237, 10.1517/14728222.2011.550879 · DOI · Paper page
  22. Stern, 2006, MHC class II compartment subtypes: structure and function, Curr. Opin. Immunol., 18, 64, 10.1016/j.coi.2005.11.005 · DOI
  23. Henne, 1995, Surface expression of the invariant chain (CD74) is independent of concomitant expression of major histocompatibility complex class II antigens, Immunology, 84, 177
  24. Bernhagen, 2007, MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment, Nat. Med., 13, 587, 10.1038/nm1567 · DOI · Paper page
  25. Gordin, 2010, c-Met and its ligand hepatocyte growth factor/scatter factor regulate mature B cell survival in a pathway induced by CD74, J. Immunol., 185, 2020, 10.4049/jimmunol.0902566 · DOI
  26. Cho, 2010, Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast, Proc. Natl. Acad. Sci. USA, 107, 11313, 10.1073/pnas.1002716107 · DOI · Paper page
  27. Vera, 2008, Cyclophosphamide-induced cystitis increases bladder CXCR4 expression and CXCR4-macrophage migration inhibitory factor association, PLoS One, 3, e3898, 10.1371/journal.pone.0003898 · DOI
  28. Moser, 2001, Lymphocyte traffic control by chemokines, Nat. Immunol., 2, 123, 10.1038/84219 · DOI · Paper page
  29. Rot, 2004, Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells, Annu. Rev. Immunol., 22, 891, 10.1146/annurev.immunol.22.012703.104543 · DOI · Paper page
  30. Thelen, 2008, How chemokines invite leukocytes to dance, Nat. Immunol., 9, 953, 10.1038/ni.f.207 · DOI · Paper page
  31. Burger-Kentischer, 2002, Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis, Circulation, 105, 1561, 10.1161/01.CIR.0000012942.49244.82 · DOI · Paper page
  32. Schober, 2004, Stabilization of atherosclerotic plaques by blockade of macrophage migration inhibitory factor after vascular injury in apolipoprotein E-deficient mice, Circulation, 109, 380, 10.1161/01.CIR.0000109201.72441.09 · DOI · Paper page
  33. Zernecke, 2008, Chemokines in atherosclerosis: an update, Arterioscler. Thromb. Vasc. Biol., 28, 1897, 10.1161/ATVBAHA.107.161174 · DOI · Paper page
  34. Dessein, 2010, Autocrine induction of invasive and metastatic phenotypes by the MIF-CXCR4 axis in drug-resistant human colon cancer cells, Cancer Res., 70, 4644, 10.1158/0008-5472.CAN-09-3828 · DOI
  35. Simons, 2011, Hypoxia-induced endothelial secretion of macrophage migration inhibitory factor and role in endothelial progenitor cell recruitment, J. Cell. Mol. Med., 15, 668, 10.1111/j.1582-4934.2010.01041.x · DOI
  36. Aguilar, 2007, Murine but not human mesenchymal stem cells generate osteosarcoma-like lesions in the lung, Stem Cells, 25, 1586, 10.1634/stemcells.2006-0762 · DOI · Paper page
  37. Fischer-Valuck, 2010, Migratory response of mesenchymal stem cells to macrophage migration inhibitory factor and its antagonist as a function of colony-forming efficiency, Biotechnol. Lett., 32, 19, 10.1007/s10529-009-0110-6 · DOI
  38. Barrilleaux, 2010, Activation of CD74 inhibits migration of human mesenchymal stem cells, In Vitro Cell. Dev. Biol. Anim., 46, 566, 10.1007/s11626-010-9279-1 · DOI
  39. Barrilleaux, 2009, Small-molecule antagonist of macrophage migration inhibitory factor enhances migratory response of mesenchymal stem cells to bronchial epithelial cells, Tissue Eng. Part A, 15, 2335, 10.1089/ten.tea.2008.0434 · DOI
  40. Rattigan, 2010, Interleukin 6 mediated recruitment of mesenchymal stem cells to the hypoxic tumor milieu, Exp. Cell Res., 316, 3417, 10.1016/j.yexcr.2010.07.002 · DOI · Paper page
  41. Kim, 2011, CXC chemokine receptor 1 enhances the ability of human umbilical cord blood-derived mesenchymal stem cells to migrate toward gliomas, Biochem. Biophys. Res. Commun., 407, 741, 10.1016/j.bbrc.2011.03.093 · DOI
  42. Dwyer, 2007, Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells, Clin. Cancer Res., 13, 5020, 10.1158/1078-0432.CCR-07-0731 · DOI · Paper page
  43. Belema-Bedada, 2008, Efficient homing of multipotent adult mesenchymal stem cells depends on FROUNT-mediated clustering of CCR2, Cell Stem Cell, 2, 566, 10.1016/j.stem.2008.03.003 · DOI · Paper page
  44. Onodera, 2004, Macrophage migration inhibitory factor up-regulates the expression of interleukin-8 messenger RNA in synovial fibroblasts of rheumatoid arthritis patients: common transcriptional regulatory mechanism between interleukin-8 and interleukin-1beta, Arthritis Rheum., 50, 1437, 10.1002/art.20190 · DOI
  45. Kim, 2007, Macrophage migration inhibitory factor upregulates angiogenic factors and correlates with clinical measures in rheumatoid arthritis, J. Rheumatol., 34, 927
  46. Binsky, 2007, IL-8 secreted in a macrophage migration-inhibitory factor- and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival, Proc. Natl. Acad. Sci. USA, 104, 13408, 10.1073/pnas.0701553104 · DOI · Paper page
  47. Cheng, 2010, Macrophage migration inhibitory factor increases leukocyte-endothelial interactions in human endothelial cells via promotion of expression of adhesion molecules, J. Immunol., 185, 1238, 10.4049/jimmunol.0904104 · DOI · Paper page
  48. Ehtesham, 2004, Glioma tropic neural stem cells consist of astrocytic precursors and their migratory capacity is mediated by CXCR4, Neoplasia, 6, 287, 10.1593/neo.03427 · DOI · Paper page
  49. Barbero, 2003, Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt, Cancer Res., 63, 1969
  50. Baron, 2011, Role of macrophage migration inhibitory factor in primary glioblastoma multiforme cells, J. Neurosci. Res., 89, 711, 10.1002/jnr.22595 · DOI

Cited by

See all 151

Metadata

Authors
Lourenco, S., Teixeira, V. H., Kalber, T., Jose, R. J., Floto, R. A., & Janes, S. M.
Venue
The Journal of Immunology
Published
2015-04-01
Volume
194
Issue
7
Pages
3463-3474
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W2127755727
Cited by
151
References
3
FWCI
6.05
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Macrophage Migration Inhibitory Factor–CXCR4 Is the Dominant Chemotactic Axis in Human Mesenchymal Stem Cell Recruitment to Tumors. https://app.cochat.ai/papers/10.4049/jimmunol.1402097
The paper
Lourenco, S., Teixeira, V. H., Kalber, T., Jose, R. J., Floto, R. A., & Janes, S. M. (2015). Macrophage Migration Inhibitory Factor–CXCR4 Is the Dominant Chemotactic Axis in Human Mesenchymal Stem Cell Recruitment to Tumors. The Journal of Immunology. https://doi.org/10.4049/jimmunol.1402097

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.